Tel Aviv

NeoGames to Participate at the Jefferies Sports Betting & iGaming Summit

Retrieved on: 
Wednesday, December 1, 2021
Sport, Nasdaq, Neogames, GLOBE, Company, Online gambling

LUXEMBOURG, Dec. 01, 2021 (GLOBE NEWSWIRE) -- NeoGames S.A. (Nasdaq: NGMS) (NeoGames or the "Company"), a technology-driven provider of end-to-end iLottery solutions, announced today that Moti Malul, Chief Executive Officer, will participate in a fireside chat at Jefferies Sports Betting & iGaming Summit on Wednesday, December 1, 2021 at 4:00 p.m. Eastern Time.

Key Points: 
  • LUXEMBOURG, Dec. 01, 2021 (GLOBE NEWSWIRE) -- NeoGames S.A. (Nasdaq: NGMS) (NeoGames or the "Company"), a technology-driven provider of end-to-end iLottery solutions, announced today that Moti Malul, Chief Executive Officer, will participate in a fireside chat at Jefferies Sports Betting & iGaming Summit on Wednesday, December 1, 2021 at 4:00 p.m. Eastern Time.
  • Access to a live webcast of the fireside chat will be available through the Investors section of the Companys website at ir.neogames.com.
  • NeoGames is a technology-driven innovator and a global provider of iLottery solutions for national and state-regulated lotteries.
  • NeoGames pioneering game studio encompasses an extensive portfolio of engaging online lottery games that deliver an entertaining player experience.

IDB Bank’s Syndication Platform Enables Merchant Financial Group to Expand its Credit Facility to $400 million

Retrieved on: 
Friday, November 19, 2021
IDB, Insurance, Asset-based lending, Merchant, IDB Bank, Foodservice, Food, High tech, Final good, GLOBE, Education, Administration, Growth, Bank, Management

The expansion involves a syndicate of 14 lenders, with IDB Bank operating as the Administrative and Collateral Agent on the transaction.

Key Points: 
  • The expansion involves a syndicate of 14 lenders, with IDB Bank operating as the Administrative and Collateral Agent on the transaction.
  • IDB has been a lender to Merchant since the groups founding and has acted as its syndication agent since 2009.
  • IDB is an established partner we could count on to engineer and guide a complex transaction, says Merchant President and CEO Adam Winters.
  • Our work with Merchant is a great example of what IDBs syndication platform can accomplish, said Chris Dowd, IDB Senior Vice President.

Endpoint Security Innovator Hysolate Introduces Hysolate Free for Sensitive Access

Retrieved on: 
Tuesday, November 16, 2021
Software as a service, VM, Organization, Forever Free, Technology, NEW, Computer, Gaps, Twitter, Eric Schmidt, GLOBE, Bessemer Venture Partners, TEL, Security, Satellite navigation device, Online shopping

TEL AVIV, Israel and NEW YORK , Nov. 16, 2021 (GLOBE NEWSWIRE) -- Hysolate , an endpoint isolation innovator, today announced the release and general availability of Hysolate Free for Sensitive Access, an expansion of its no-cost Hysolate Free OS isolation solution.

Key Points: 
  • TEL AVIV, Israel and NEW YORK , Nov. 16, 2021 (GLOBE NEWSWIRE) -- Hysolate , an endpoint isolation innovator, today announced the release and general availability of Hysolate Free for Sensitive Access, an expansion of its no-cost Hysolate Free OS isolation solution.
  • Hysolate Free for Sensitive Access empowers users to work with sensitive or private data and applications in an isolated workspace on their Windows 10 or 11 devices.
  • Todays announcement of the general availability of Hysolate Free for Sensitive Access introduces a second use case for Hysolates isolated virtual environments.
  • We are delighted to launch Hysolate Free for Sensitive Access.

NeoGames Announces Third Quarter 2021 Results

Retrieved on: 
Wednesday, November 10, 2021

LUXEMBOURG, Nov. 10, 2021 (GLOBE NEWSWIRE) -- NeoGames S.A. (Nasdaq: NGMS) (“NeoGames” or the "Company"), a technology-driven provider of end-to-end iLottery solutions, announced today financial results for the third quarter ended September 30, 2021.

Key Points: 

Sun Capital Partners Co-CEO Marc J. Leder Receives Prestigious Yitzhak Rabin Financial Leadership Award from American Friends of Rabin Medical Center

Retrieved on: 
Wednesday, November 10, 2021
Hospitals, Professional Services, Health, Finance, Health, Yitzhak Rabin, Rabin Medical Center, University, NHS Business Services Authority, Boca Raton Regional Hospital, Sun Capital Partners, Charity: Water, Wendell Pritchett, Tel Aviv, Berggruen Museum, Corporate services, Leadership, Friends, American Friends, International Council, Institute, Technology, Organic, Multimedia, Research, Zanvyl Krieger School of Arts and Sciences, Board, Award, Wharton School of the University of Pennsylvania, Physician, Consumer, RMC, Patient, School, Religion, Samuel, Management, Hospital, American Friends of Rabin Medical Center, Sun Capital Partners, Inc., AMERICAN FRIENDS OF RABIN MEDICAL CENTER, SUN CAPITAL PARTNERS, INC.

Marc J. Leder, co-founder and co-CEO of Sun Capital Partners, Inc., was honored with the Yitzhak Rabin Financial Leadership Award by American Friends of Rabin Medical Center (AFRMC) at its annual gala on November 8, 2021, in New York.

Key Points: 
  • Marc J. Leder, co-founder and co-CEO of Sun Capital Partners, Inc., was honored with the Yitzhak Rabin Financial Leadership Award by American Friends of Rabin Medical Center (AFRMC) at its annual gala on November 8, 2021, in New York.
  • View the full release here: https://www.businesswire.com/news/home/20211110006001/en/
    Marc J. Leder, Co-Founder & Co-CEO, Sun Capital Partners (right) receives Yitzhak Rabin Financial Leadership Award from Rodger Krouse, Co-Founder & Co-CEO, Sun Capital Partners (left).
  • (Photo: Business Wire)
    We are thrilled to present Marc Leder with this years Yitzhak Rabin Financial Leadership Award, said Rabbi Joshua Eli Plaut, Ph.D., Executive Director of AFRMC.
  • I am humbled to be honored with the Yitzhak Rabin Financial Leadership Award this year, said Leder.

InspireMD Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, November 9, 2021
Stent, Evaluation, Call, HAS, LPPR, JACC, Industry, Medical device, Clinical trial, EPS, CAD, CEO, Safety, COVID, Growth, Stroke, COVID-19, NSPR, Principal, Stenosis, Partnership, Efficacy, Multicenter trial, Palestinian National Authority, Hospital, Company, GLOBE, Randomized controlled trial, National Commission, Physician, American College of Cardiology, Marketing, Nasdaq, Patient, TEL, FDA, American College, Animal, Pharmaceutical industry, Health insurance

TEL AVIV, Israel, Nov. 09, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced financial and operating results as of and for the third quarter ended September 30, 2021.

Key Points: 
  • For the nine months ended September 30, 2021, CGuard revenue increased by 45.4% compared to the same period in 2020.
  • Financial Results for the Third Quarter ended September 30, 2021
    For the three months ended September 30, 2021, revenue increased by $91,000, or 9.3%, to $1,071,000, from $980,000 during the three months ended September 30, 2020.
  • Total operating expenses for the quarter ended September 30, 2021 were $4,123,000, an increase of 65.4% compared to $2,493,000 for the same period in 2020.
  • For the three months ended September 30, 2021, financial expenses increased by 5.3%, or $2,000, to $40,000, from $38,000 during the three months ended September 30, 2020.

A2Z Smart Technologies to Present at the Q4 Investor Summit

Retrieved on: 
Monday, November 8, 2021
News, Person, TSX Venture Exchange, SEDAR, Advertising, Intention, Company, Marketing, SAAS, Online shopping

Tel Aviv, Israel--(Newsfile Corp. - November 8, 2021) - A2Z Smart Technologies Corp. (TSXV: AZ) (OTCQB: AAZZF) ("A2Z" or the "Company"), today announced their participation in the Q4 Investor Summit.

Key Points: 
  • Tel Aviv, Israel--(Newsfile Corp. - November 8, 2021) - A2Z Smart Technologies Corp. (TSXV: AZ) (OTCQB: AAZZF) ("A2Z" or the "Company"), today announced their participation in the Q4 Investor Summit.
  • Interested investors can view the live presentation at this link:
    A replay of the presentation will be available at the above link for 90 days following the conference.
  • A2Z Smart Technologies Corp. creates innovative solutions for complex challenges.
  • Additional A2Z products include advanced automotive fire prevention systems, bomb-defusing robots, and portable energy systems.

InspireMD Announces Publication of 12-Month Results of CGuard™ EPS SIBERIA Trial in Journals of the American College of Cardiology: Cardiovascular Interventions

Retrieved on: 
Wednesday, November 3, 2021
TEL, JACC, EPS, Compliance, Technology, Industry, CAD, Security (finance), U.S. Securities and Exchange Commission, Randomized controlled trial, Cerebral infarction, NSPR, Micronet, SEC, Xi, Stenosis, Trial of the century, Brain, Forward-looking statement, Regression dilution, Company, Standard of care, Clinical trial, Stroke, American College, Nasdaq, CAS, Risk, GLOBE, Sale, Physician, Pharmaceutical industry, Medical imaging

The principal investigator study was published in Journals of the American College of Cardiology (JACC) and is titled Randomized Controlled Trial of Conventional Versus MicroNet-Covered Stent in Carotid Artery Revascularization.

Key Points: 
  • The principal investigator study was published in Journals of the American College of Cardiology (JACC) and is titled Randomized Controlled Trial of Conventional Versus MicroNet-Covered Stent in Carotid Artery Revascularization.
  • This data constitutes level 1 evidence in favor of a CGuard MicroNet-covered stent in demonstrating reduction of cerebral infarcts in neuroprotective CAS versus Acculink.
  • This randomized control study evaluated 30-day silent brain infarcts associated with the use of the Acculink conventional open-cell nitinol stent vs the CGuard MicroNet-covered stent.
  • Investors and security holders are urged to read these documents free of charge on the SECs web site at http://www.sec.gov.

Purple Biotech to Present at the Jefferies London Healthcare Conference

Retrieved on: 
Wednesday, November 3, 2021
CM24, Head, Pancreatic cancer, Cetuximab, Hypertension, Survival, SCCHN, Patient, Celecoxib, FDA, Large-cell lung carcinoma, Cancer, PD-1, Conference, Marketing, CEACAM1, Company, Bristol Myers Squibb, Nivolumab, STAT3, Drug resistance, GLOBE, Neck, Pharmaceutical industry

REHOVOT, Israel, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" ", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, today announced that management will present a corporate overview at the Jefferies London Healthcare Conference on Wednesday, November 17, 2021 at 12:20 pm GMT.

Key Points: 
  • REHOVOT, Israel, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" ", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, today announced that management will present a corporate overview at the Jefferies London Healthcare Conference on Wednesday, November 17, 2021 at 12:20 pm GMT.
  • The conference will take place from November 16 - 19, 2021.
  • Jefferies London Healthcare Conference - November 16-19, 2021
    Purple Biotech Ltd. is a clinical-stage company developing first-in-class therapies by overcoming tumor immune evasion and drug resistance.
  • CM24 is a humanized monoclonal antibody that blocks CEACAM1, an immune checkpoint protein that supports tumor immune evasion and survival through multiple pathways.

Quentin Tarantino Revealed as Iconic Artist Behind First-Ever Secret NFTs, Showcasing Never-Before-Seen Work Revealed Only to NFT Owner

Retrieved on: 
Tuesday, November 2, 2021
Ethereum, Digital, Technology, NFT, CA, Espionage, Rome Film Festival, Privacy, Pulp Fiction, RPG, Cannes, Academy Awards, Collection, List of common film awards categories, CEO, Innovation, Oscar, Non-fungible token, GLOBE, Ownership, Cannes Film Festival, Secrecy, Film, Cryptocurrency, Auction

Each NFT at auction contains secret content viewable only by the owner of the NFT, a groundbreaking and unique feature enabled by Secret NFTs.

Key Points: 
  • Each NFT at auction contains secret content viewable only by the owner of the NFT, a groundbreaking and unique feature enabled by Secret NFTs.
  • The public metadata of the NFT - the front cover of this exclusive content - is rare in its own right: a unique, never-before-seen, public-facing work of art.
  • Secret Network and Secret NFTs provide a whole new world of connecting fans and artists and Im thrilled to be a part of that.
  • Secret NFTs - unique private-by-default non-fungible tokens issued on Secret Network - are reigniting conversations in the art community around public and private access to content.